Viewing Study NCT06611657


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-02-25 @ 6:34 PM
Study NCT ID: NCT06611657
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-16
First Post: 2024-09-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NCC2766
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators